Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.60 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.56 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.51 |
| ▸ | GNPAT | O15228 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10599969 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10602700 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL4609045 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10603409 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10599977 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL5982247 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10600983 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10599643 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL10603414 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT | |
| SCHEMBL21801849 | 1.00 | NOD1 (0.60) | NOD1SIRT6SIRT1GPR84MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3865591-B1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S R L (IT) | 2024-04-03 | — | — | EP | claimed |
| US-20230080158-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S.R.L. (IT) | 2023-03-16 | — | — | US | claimed |
| US-20220208386-A1 | DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-06-30 | — | — | US | claimed |
| US-20220118269-A1 | MONITORING EFFICACY OF MAGNETIC AND ELECTRIC FIELDS USING BIOMARKERS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2022-04-21 | — | — | US | claimed |
| EP-3947732-A2 | DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER | Arizona Board of Regents on behalf of Arizona State University (US) | 2022-02-09 | — | — | EP | claimed |
| WO-2021161208-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S.R.L. (IT) | 2021-08-19 | — | — | WO | claimed |
| EP-3865591-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | Cardiomix S.r.l. (IT) | 2021-08-18 | — | — | EP | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| EP-3865591-B1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S R L (IT) | 2024-04-03 | — | — | EP | disclosed |
| US-11850440-B2 | Therapeutic systems using magnetic fields | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-12-26 | — | — | US | disclosed |
| US-20230091156-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2023-03-23 | — | — | US | disclosed |
| US-20220102000-A1 | PREDICTING BLOOD METABOLITES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-03-31 | — | — | US | disclosed |
| EP-3947732-A2 | DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER | Arizona Board of Regents on behalf of Arizona State University (US) | 2022-02-09 | — | — | EP | disclosed |
| WO-2021161208-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S.R.L. (IT) | 2021-08-19 | — | — | WO | disclosed |
| EP-3865591-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | Cardiomix S.r.l. (IT) | 2021-08-18 | — | — | EP | disclosed |
| US-20210052910-A1 | THERAPEUTIC SYSTEMS USING MAGNETIC FIELDS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2021-02-25 | — | — | US | disclosed |
| EP-0973710-A2 | OMEGA-AMINO ACID DERIVATIVES, PROCESSES OF THEIR PREPARATION AND THEIR USE | Bochemie S.R.O. (CZ) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998045233-A2 | OMEGA-AMINO ACID DERIVATIVES, PROCESSES OF THEIR PREPARATION AND THEIR USE | BOCHEMIE S.R.O. (CZ) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | CYP27A1, LIPC, CYP46A1 | NOD1 3025/4885SIRT6 2548/4885SIRT1 1869/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | NOD1 3811/4885SIRT6 789/4885SIRT1 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.